Opium Tincture Deodorizedmorphine

According to the FDA label: Opium tincture is useful for the treatment of diarrhea.

72,905 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Opium Tincture Deodorized in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Opium Tincture Deodorized adverse event reports by reporter sex
SexReports
Female36,375
Male30,682
Unknown294

By Age Group

View age group data as a table
Opium Tincture Deodorized adverse event reports by reporter age group
Age groupReports
0-173,279
18-346,332
35-4910,284
50-6416,623
65-749,369
75+6,456

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Opium Tincture Deodorized. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Opium Tincture Deodorized adverse event reports by reported outcome
OutcomeReports
Other Serious35,517
Hospitalization30,099
Death20,084
Non-Serious9,371
Life-Threatening6,412
Disability2,464

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Opium Tincture Deodorized. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Opium Tincture Deodorized adverse event reports by year
YearReports
19982
19992
20011
20033
20041,022
20051,294
20061,346
20071,250
20081,662
20091,669
20102,265
20112,528
20123,119
20133,049
20143,429
20153,840
20164,095
20174,240
20184,852
20195,288
20205,946
20215,174
20224,260
20234,448
20244,183
20253,257
2026 (partial)681

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Opium Tincture Deodorized

In FDA adverse event reports that mention Opium Tincture Deodorized, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026